|
If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | |||||||||||||||||||
  Acta Psychiatrica ScandinavicaVolume 114 Issue 1, Pages 40 - 48 Published Online: 14 Mar 2006 © 2010 John Wiley & Sons A/S
Abstract | References | Full Text: HTML, PDF (Size: 162K) | Related Articles | Citation Tracking  Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia Copyright 2006 The Authors Journal Compilation 2006 Blackwell Munksgaard KEYWORDS prevalence • schizophrenia • signs and symptoms •
Toxoplasmosis
Wang H-L, Wang G-H, Li Q-Y, Shu C, Jiang M-S, Guo Y. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. ABSTRACTObjective: To compare the prevalence of Toxoplasma infection between the first-episode schizophrenia and the controls and to compare the clinical features between the Toxoplasma-seronegative and Toxoplasma-seropositive patients with schizophrenia. Method: The rate of serum reactivity toToxoplasma in 600 schizophrenia, 600 affective disorders, and 400 controls was investigated. The clinical symptoms of the schizophrenia patients were scored and compared. Results: The rate of IgG antibody, not IgM in the schizophrenia patients, was higher than the control groups, and the odds ratio of schizophrenia associated with IgG antibody was 2.22–5.12. The affective disorders did not differ in the rate of IgG or IgM antibody from the normal or the physical disease control. The seropositive schizophrenia patients had higher scores on the positive subscale and three components of Positive and Negative Symptoms Scale than the seronegative patients. Conclusion: This study lent further weight to the hypothesis that exposure to Toxoplasma may be a risk factor for schizophrenia. Accepted for publication January 2, 2006 | 
|
|
| ||||||||||||||||
|
|
|||||||||||||||||||
 | Personality and Mental Health |
| |
